✦ LIBER ✦

FDA Perspective on Regulatory Issues in Vaccine Development

✍ Scribed by BASCOM F. ANTHONY

Book ID: 119872292
Publisher: John Wiley and Sons
Year: 1995
Tongue: English
Weight: 404 KB
Volume: 754
Category: Article
ISSN: 0890-6564
DOI: 10.1111/j.1749-6632.1995.tb44432.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Preclinical Development Handbook || Regu

Preclinical Development Handbook || Regulatory Issues in Preclinical Safety Studies (U.S. FDA)

✍ Gad, Shayne Cox 📂 Article 📅 2008 🏛 John Wiley & Sons, Inc. 🌐 English ⚖ 149 KB

A clear, straightforward resource to guide you through preclinical drug development Following this book's step-by-step guidance, you can successfully initiate and complete critical phases of preclinical drug development. The book serves as a basic,comprehensive reference to prioritizing and optimiz

FDA perspective on peptide formulation a

FDA perspective on peptide formulation and stability issues

✍ Chien-Hua Niu; Yuan-Yuan Chiu 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 36 KB

The FDA perspective on the development o

The FDA perspective on the development of stereoisomers

✍ Wilson H. De Camp 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 723 KB

Regulatory watch: FDA guidance on co-dev

Regulatory watch: FDA guidance on co-developing investigational drugs

📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 165 KB

Issues in malaria vaccine development

✍ V. ANN STEWART; R. COPPEL 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 183 KB

The role of standards in FDA marketing c

The role of standards in FDA marketing clearance - regulatory issues

✍ Munzner, R. 📂 Article 📅 2004 🏛 IEEE 🌐 English ⚖ 213 KB